Risk factors

Eloxx Pharmaceuticals (ELOX) risk factors

Item 1A of every Eloxx Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next.

Open ELOX in Gloomberb →
  • FY2025 10-K risk factors

    79 risks. Eloxx Pharmaceuticals faces severe going concern doubts, with insufficient cash for the next twelve months and an accumulated deficit of $300.6 million. Delinquent public filings, delisting from Nasdaq, and dependence on its lead product candidate, exaluren, heavily threaten operations.

    Filed Mar 17, 2026